Bolaños-Jiménez F, Manhães de Castro R, Fillion G
Unité de Pharmacologie Neuro-Immuno-Endocrinienne, Institut Pasteur, Paris, France.
Neuropharmacology. 1994 Jan;33(1):77-81. doi: 10.1016/0028-3908(94)90099-x.
The effect of long term treatment with two tricyclic antidepressants on the sensitivity of 5-HT1B presynaptic heteroreceptors inhibiting acetylcholine (ACh) release was investigated. Groups of male rats received during 14 days either saline, citalopram (20 mg/kg), a serotonin (5-HT) uptake blocker, or tianeptine (2 x 10 mg/kg), an antidepressant that enhances 5-HT uptake. The efficacy of the 5-HT1B selective agonist 7-trifluoromethyl-4-(4-1-piperazinyl)-pyrrolo[1,2-a]quinoxaline (CGS 12066B) in reducing K(+)-evoked [3H]acetylcholine release from hippocampal synaptosomes was determined 24 hr after the last administration. The chronic treatment with citalopram or tianeptine modified neither the basal nor the K(+)-evoked release of [3H]acetylcholine. In contrast, these treatments significantly reduced the efficacy of CGS 12066B to inhibit the release of [3H]acetylcholine induced by K+ depolarization. These data suggest that chronic antidepressant treatment desensitizes 5-HT1B presynaptic heteroreceptors through a mechanism which seems to be independent of the synaptic availability of 5-HT.
研究了两种三环类抗抑郁药长期治疗对抑制乙酰胆碱(ACh)释放的5-HT1B突触前异受体敏感性的影响。将雄性大鼠分组,连续14天分别给予生理盐水、西酞普兰(20mg/kg)(一种5-羟色胺(5-HT)摄取阻滞剂)或噻奈普汀(2×10mg/kg)(一种增强5-HT摄取的抗抑郁药)。在末次给药24小时后,测定5-HT1B选择性激动剂7-三氟甲基-4-(4-1-哌嗪基)-吡咯并[1,2-a]喹喔啉(CGS 12066B)降低海马突触体中K⁺诱发的[³H]乙酰胆碱释放的效力。西酞普兰或噻奈普汀的长期治疗既未改变[³H]乙酰胆碱的基础释放,也未改变K⁺诱发的释放。相反,这些治疗显著降低了CGS 12066B抑制K⁺去极化诱导的[³H]乙酰胆碱释放的效力。这些数据表明,慢性抗抑郁药治疗通过一种似乎独立于5-HT突触可用性的机制使5-HT1B突触前异受体脱敏。